In colorectal cancer, overexpression of ATF4 has been related to oxaliplatin and 5-fluorouracil resistance [73], while ATF4 downregulation delayed tumour growth of endometrial cancer xenografts [74] (Table 2). Here, ATF4 is linked to endometrial cancer.